Board MeetingAug 13, 2026, 09:36 AM
Ascentage Pharma to Report H1 2026 Results on August 19
AI Summary
Ascentage Pharma Group International announced it will release its 2026 six-month unaudited interim results and provide business updates on August 19, 2026, with an investor webcast scheduled for 7:00 am EDT. The company also corrected the timing for its English language investor conference call to August 20, 2026, at 8:00 am EDT. Additionally, Ascentage Pharma management will participate in the Evercore 2nd Annual China Biotech Summit from August 17-19, 2026, including a fireside chat and one-on-one investor meetings.
Key Highlights
- Ascentage Pharma to release 2026 six-month interim results on August 19, 2026.
- Investor webcast with Q&A for interim results scheduled for August 19, 2026, at 7:00 am EDT.
- English language investor conference call for results on August 20, 2026, at 8:00 am EDT.
- Company management will participate in the Evercore 2nd Annual China Biotech Summit.
- Fireside chat at the summit on August 18, 2026, at 7:45-8:00 am Beijing Time.
- One-on-one investor meetings will also be held during the summit.
Price Impact
More from AAPG